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研究及证实慈济化癌保生方（Ciji Hua’ai Baosheng Formula, CHBF）对肝癌
H22 荷瘤小鼠化疗后肿瘤微血管的影响。通过观察小鼠一般生存状况、测量体重、
瘤重和计算抑瘤率，观察肿瘤微血管密度（microvessel density，MVD）以及对
血清与肿瘤组织血管内皮生长因子（vascular endothelial growth factor，VEGF）、
VEGF 受体-含激酶插入结构域的受体（kinase insert domain-containing receptor， 




以 SPF（specific pathogen-free）级 Kunming 种小鼠 60 只，4 周龄，18-22g，





组、CHBF 高剂量（117g/kg）组、CHBF 中剂量（58.5g/kg）组、CHBF 低剂量
（29.25g/kg）组，共 5 组，每组 12 只，给予正常饲料、饮水，除模型组以生理
盐水灌胃干预，其他组分别予以不同药物进行干预。期间观察小鼠一般生存状态，
连续给药 10 天后，称重，眼球取血，处死剥离肿瘤，称取瘤重，计算抑瘤率；
3000r/min 离心 15min 分离出血清。苏木精-伊红（hematoxylin-eosin，HE）染色
法瘤组织切片，光镜下观察肿瘤组织病理结构改变；采用酶联免疫法
（enzyme-linked immunosorbent assay，ELISA）法检测外周血清及肿瘤组织混悬
液 VEGF、KDR、bFGF 含量；免疫组化法检测 CD34 标记的肿瘤微血管密度（MVD）
值；免疫组化法检测 VEGF、bFGF 抗体标记的肿瘤 VEGF、bFGF 的表达；采用
蛋白印迹法（western blot，WB）检测肿瘤 VEGF、bFGF 蛋白表达情况。 
研究结果： 















低于 CTX 组； 
2. HE 染色后，模型组巨核细胞分布密集、杂乱，其余各组均不同程度好于
模型组；CTX 组及 CHBF 中高剂量组 MVD 显著低于模型组，差异具有统计学
意义，其中 CHBF 高剂量组 MVD 显著低于 CTX 组； 
3. 采用 ELISA、免疫组化、WB 法检测外周血清及肿瘤组织 VEGF 含量，
CHBF 高剂量组结果均显著好于模型组，CHBF 高剂量组部分结果好于 CTX 组；
外周血清及肿瘤组织 KDR 含量，CHBF 各剂量组结果均好于模型组；外周血清
及肿瘤组织 bFGF 含量，CHBF 高剂量组结果均显著好于模型组，CHBF 高剂量
组部分结果好于 CTX 组。 
结论： 
1. 慈济化癌保生方可以抑制化疗后肝癌 H22 荷瘤小鼠的血管生成； 
2. 慈济化癌保生方可以通过抑制荷瘤小鼠肝癌组织释放的因子如 VEGF、


















PURPOSE: This experiment is to study of investigating the effect of Ciji Hua’ai 
Baoshengfang Formula (CHBF) on tumor angiogenesis in mice receiving 
chemotherapy for the treatment of H22 hepatocellular carcinoma. By observing the 
survival state, body weight, tumor tissue weight and calculating the tumor inhibition 
ratios. Observe the microvessel density (MVD) and vascular endothelial growth factor 
(VEGF), kinase insert domain-containing receptor (KDR) and basic fibroblast growth 
factor (bFGF) expression in serum and tumor tissue. This research aims at clearing the 
mechanism of CHBF affecting tumor angiogenesis, and will provide a scientific 
evidence for CHBF in clinical research and application. 
METHODS: Sixty Kunming mice with specific pathogen-free were injected 
subcutaneously with H22 hepatoma carcinoma cell suspensions (2×10
7
/ml diluted)  
into the right anterior armpit. Seven days later, all transplanted tumor were formed 
and the mice were received intraperitoneal injection with 200mg/kg cytoxan (CTX) to 
establish the tumor-bearing mouse chemotherapy model, randomly divided into model 
group, continuing CTX chemotherapy group (CTX group), and three CHBF (117g/kg, 
58.5g/kg and 29.25g/kg) groups , with 12 mice in each group. The model group was 
given intragastric administration of normal saline. The other group was treated with 
different drugs. Survival state was observed. They were administered next day after 
making model. Mice were given conventional feed and water. After 10 days of 
continuous dosing, mice were sacrificed after fasting 24 hours and remove specimens. 
Mice were weighed and taked blood by removing eyeballs, the transplanted tumors 
were stripped, weighed the tumor, calculated the the tumor inhibition ratios, isolated 
serum with 3000r/min in 15min. Pathological tissue structural change through 
Hematoxylin-eosin(HE) staining was detected by light microscope. Observing 
histology, contents of VEGF, KDR and bFGF in serum and tumor tissue were 
measured by enzyme-linked immunosorbent assay (ELISA), VEGF and bFGF protein 
expression and MVD tagged by CD34 were detected by immunohistochemisty, VEGF 
and bFGF protein expression were detected by western blot. 
RESULTS:  
1. CHBF could improve the survival quality of mice receiving chemotherapy in 














group. CHBF groups’ body weight loss was not obvious, and CTX group could 
significantly reduced the body weight. Tumor tissue weight of CHBF groups was 
significantly reduced, but tumor inhibition ratios of each CHBF group were not higher 
than CTX group. 
3. After stained the tumor tissue with HE, the megakaryocyte of model group densely 
and disorderedly distributed under the light microscope.The other groups were better 
than model group in different degrees. MVD in CHBF (117g/kg, 58.5g/kg) and CTX 
groups was significantly lower than that in model group (P<0.01). CHBF (117g/kg) 
group was also less than that in CTX group (P<0.05; P<0.01). 
4. VEGF expression of serum and tumor tissue in CHBF (117g/kg) group were less 
than that in model group (P<0.05; P<0.01) by ELSIA, immunohistochemisty and 
western blot methods. Some of that were also less than that in CTX group (P<0.05; 
P<0.01). KDR expression of serum and tumor tissue in each CHBF groups were less 
than that in model group (P<0.05; P<0.01) by ELSIA method. BFGF expression of 
serum and tumor tissue in CHBF (117g/kg) group were less than that in model group 
(P<0.01) by ELSIA, immunohistochemisty and western blot methods. Some of that 
were also less than that in CTX group (P<0.01). 
CONCLUSION:  
1. CHBF with a certain concentration can effectively decrease MVD to inhibit tumor 
capillary vessel growth of mice receiving chemotherapy for the treatment of H22 
hepatocellular carcinoma. 
2. CHBF with a certain concentration can effectively reduce the expression of VEGF, 
KDR and bFGF. That indicates CHBF with a certain concentration has the effect of 
reducing angiogenetic factors to inhibit tumor capillary vessel growth. 
KEY WORDS: Ciji Hua’ai Baosheng Formula (CHBF); tumor angiogenesis; 
microvessel density (MVD); vascular endothelial growth factor (VEGF); kinase insert 
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英 文 缩 略 词 表 
英文缩写 英文全称 中文全称 
bFGF Basic fibroblast growth factor 
碱性成纤维细胞生长
因子 
CHBF Ciji Hua’ai Baosheng Formula 慈济化癌保生方 
CTX Cytoxan 环磷酰胺 
ELISA Enzyme-linked immunosorbent assay 酶联免疫吸附测定 
HE Hematoxylin-eosin 苏木精-伊红 
IOD Integral optical density 积分光密度 
KDR Kinase insert domain-containing receptor 
含激酶插入结构域受
体 
MVD Microvessel density 微血管密度 
OD Optical density 光密度 
SPF Specific pathogen-free 无特定病原体 
VEGF Vascular endothelial growth factor 血管内皮生长因子 


















































SPF 级 Kunming 种小鼠 60 只，4 周龄，18-22g，以传代 H22 肝癌细胞悬液右腋
皮下注射，随机分为 5 组，每组 12 只，待肉眼观察到肿瘤组织长出后以 CTX





















肿瘤组织 肿瘤组织研磨液 血清 
统计数据，分析结果 
免疫组化检测 VEGF、bFGF 


















据 WHO 2000 年资料显示全球死于癌症的患者超过 700 万，占发达国家居












































度(microvessel density，MVD)，血清与肿瘤组织血管内皮生长因子 (vascular 
endothelial growth factor，VEGF)、VEGF 受体-含激酶插入结构域的受体(kinase 
insert domain-containing receptor，KDR)、碱性成纤维细胞生长因子  (basic 
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